Trial Profile
Monoclonal antibody treatment for non-Hodgkin's lymphoma (low grade)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Epratuzumab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 25 Sep 2005 New trial record.